Politics News

Republicans raise U.S. drug supply concerns after coronavirus outbreak

imagePolitics6 hours ago (Feb 24, 2020 03:13PM ET)

NEW YORK (Reuters) – Republicans raised concerns this week about the security of the U.S. drug supply chain in the wake of the coronavirus outbreak in China, where a significant portion of the ingredients used to make prescription drugs is manufactured.

The outbreak highlights “severe, longstanding, and unresolved vulnerabilities in our capacity to produce life-saving pharmaceutical drugs and medical devices for our own citizens,” Missouri Senator Josh Hawley wrote in a letter to the U.S. Food and Drug Administration. “This is unacceptable.”

Around 88 percent of the active pharmaceutical ingredients (API) used in drugs for the U.S. market were manufactured overseas in 2018, according to the FDA https://www.fda.gov/media/131130/download. About 14 percent of the API for U.S. drugs in that year was produced in China, the FDA said.

Axios reported https://www.axios.com/coronavirus-threatens-drug-shortage-318c9e7b-5d92-4a5e-b992-2478023c6d01.html?utm_source=newsletter&utm_medium=email&utm_campaign=newsletter_axiosam&stream=top on Sunday that around 150 prescription drugs are at risk of shortage if the outbreak worsens, citing a list of at risk drugs compiled by the FDA that includes antibiotics generics, and some branded drugs.

A spokesperson for the FDA could not be immediately reached for comment.

White House trade adviser Peter Navarro, is working on medical supply chain issues related to coronavirus and said yesterday on Fox News Channel’s “Sunday Morning Futures” that too much is produced overseas.

“We have offshored far too much of our supply chain … for the essential medicines we need,” Navarro said. “A lot of it’s in China. Some of it’s in India. Some of it’s in Europe. But we’ve got to get that back onshore,” he said.

Republicans raise U.S. drug supply concerns after coronavirus outbreak

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles

Back to top button